Shanghai Runda Medical Technology Co., Ltd.

Shanghai Stock Exchange 603108.SS

Shanghai Runda Medical Technology Co., Ltd. Operating Income for the year ending December 31, 2023: USD 91.10 M

Shanghai Runda Medical Technology Co., Ltd. Operating Income is USD 91.10 M for the year ending December 31, 2023, a -56.30% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Shanghai Runda Medical Technology Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 208.49 M, a 15.10% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 181.15 M, a 17.97% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 153.55 M, a 1.57% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 151.18 M, a 79.97% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Shanghai Stock Exchange: 603108.SS

Shanghai Runda Medical Technology Co., Ltd.

CEO	Mr. Cheng Xu Zhang
IPO Date	May 27, 2015
Location	China
Headquarters	Xinghui (Landmark) Center
Employees	3,315
Sector	Health Care
Industries Medical Instruments Biotechnology Hospitals & Clinics Pharmaceuticals

Description

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.

Key trends

Past 5 years